The role of CHMP2BIntron5 in autophagy and frontotemporal dementia - PubMed (original) (raw)

Review

The role of CHMP2BIntron5 in autophagy and frontotemporal dementia

Christopher S Krasniak et al. Brain Res. 2016.

Abstract

Charged multivesicular body protein 2B (CHMP2B) - a component of the endosomal complex required for transport-III (ESCRT-III) - is responsible for the vital membrane deformation functions in autophagy and endolysosomal trafficking. A dominant mutation in CHMP2B (CHMP2BIntron5) is associated with a subset of heritable frontotemporal dementia - frontotemporal dementia linked to chromosome 3 (FTD-3). ESCRT-III recruits Vps4, an AAA-ATPase that abscises the membrane during various cellular processes including autophagy and intraluminal vesicle formation. CHMP2BIntron5 results in a C-terminus truncation removing an important Vps4 binding site as well as eliminating the normal autoinhibitory resting state of CHMP2B. CHMP2B is expressed in most cell types but seems to be especially vital for proper neuronal function. CHMP2BIntron5-mediated phenotypes include misregulation of transmembrane receptors, accumulation of multilamellar structures, abnormal lysosomal morphology, down regulation of a brain-specific micro RNA (miRNA-124), abnormal dendritic spine morphology, decrease in dendritic arborization, and cell death. Currently, transgenic-fly,-mouse, and -human cell lines are being used to better understand the diverse phenotypes and develop therapeutic approaches for the CHMP2BIntron5-induced FTD-3. This article is part of a Special Issue entitled SI:Autophagy.

Keywords: Autophagy; CHMP2B(Intron5); ESCRT-III; Endolysosome; FTD-ALS; Frontotemporal dementia.

Copyright © 2016 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Mutations in the CHMP2B gene causing FTD and other neurodegenerative diseases. A. There are several CHMP2B mutations that have been found to cause diseases on the FTD-ALS spectrum (I29V, T104N, D148Y, Q165X, M178V, and Q206H; orange boxes) as well as other neurodegenerative disorders; corticobasal degeneration caused by N143S (purple box). B. Functional wild type CHMP2B domains and altered CHMP2BIntron5 protein. Wild type CHMP2B is a 213 amino acid protein with two coiled-coil (CC) domains as well as a microtubule interacting and transport interacting motif (MIM). The N-terminus contains basic alpha helices and the C-terminus contains acidic alpha helices, leading to an auto-inhibitory self-binding. CHMP2BIntron5 loses much of the acidic C-terminus, decreasing its autoinhibition and removing the MIM, which is a Vps4 binding site. E, Exon; PMA, primary muscular atrophy; CBD, corticobasal degeneration; SD, semantic dementia; FTD, frontotemporal dementia; * denotes mutation causing CHMP2BIntron5 and CHMP2BDelta10.

Figure 2

Figure 2

CHMP2BIntron5 causes a diverse array of neuronal pathologies. The known molecular and structural bases of this neurodegeneration include: misregulation of miRNA, accumulation of autophagosomes and MVBs, abnormally sized lysosomes, a decrease in dendritic arborization, an overall increase in dendritic spines but with a decrease in mushroom spines, and misregulation of receptors such as Notch, and EGFR. These pathologies combined not only weaken the cell, but also leads to death of many frontal and temporal neurons.

Similar articles

Cited by

References

    1. Ahmad ST, et al. Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementia. Proc Natl Acad Sci U S A. 2009;106:12168–73. - PMC - PubMed
    1. Ahmad ST, Lee J-A. Molecular Mechanisms Underlying the Role of Autophagy in Neurodegenerative Diseases. 2014:45–59.
    1. Anderson KN, et al. Disrupted sleep and circadian patterns in frontotemporal dementia. Eur J Neurol. 2009;16:317–23. - PubMed
    1. Bajorek M, et al. Structural basis for ESCRT-III protein autoinhibition. Nature Structural & Molecular Biology. 2009;16:754–762. - PMC - PubMed
    1. Baker M, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916–9. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources